TP53 and myelodysplastic syndrome: Using sensitive amplicon deep sequencing to analyze serial samples, we determined the incidence of TP53 gene mutations in lower-risk MDS patients, the effect of TP53 mutations on OS and PFS, the impact of treatment on mutational burden, and the level of the mutational burden with regard to the typeof cell population.